首页 > 最新文献

Archivos De La Sociedad Espanola De Oftalmologia最新文献

英文 中文
Colocación simultánea de un implante de cemento óseo posterior a cirugía de evisceración en pacientes con diagnóstico de endoftalmitis infecciosa
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.09.003
E.S. Barillas Escobar, J.L. Tovilla Canales, O. Olvera Morales, E.G. Castillo Pérez, A. Nava-Castañeda

Background and objectives

Endophthalmitis is a type of eye inflammation that affects all structures of the eye and is generally of infectious origin. In cases recalcitrant to intravitreal treatment or posterior vitrectomy, evisceration or enucleation are the preferable options. Polymethylmethacrylate (PMMA) bone cement stands out as an implant in other areas of medicine due to its great stability and healing. In this study, we will evaluate the safety profile and extrusion rate of the antibiotic-reinforced bone cement implantation when it is decided to place it at the same surgical act as an evisceration indicated for infective endophthalmitis.

Materials and methods

Subjects of any age and gender from the Oculoplastic outpatient clinic of Instituto de Oftalmología Fundación Conde de Valenciana, with a diagnosis of infectious endophthalmitis who required evisceration from May throught October 2012 were included.

Results

A total of 20 subjects were included, 55% of whom were men (11) 45% women (9), with mean age of 51 up to 80 years. No complications were evidenced in the immediate postoperative period or at 1, 3 and 6 months follow up, and in all cases, the correct position of the implant was confirmed via computed tomography.

Conclusions

In patients diagnosed with infectious endophthalmitis of any cause, evisceration and bone cement implatation in a single surgical act is a safe and effective option.
{"title":"Colocación simultánea de un implante de cemento óseo posterior a cirugía de evisceración en pacientes con diagnóstico de endoftalmitis infecciosa","authors":"E.S. Barillas Escobar,&nbsp;J.L. Tovilla Canales,&nbsp;O. Olvera Morales,&nbsp;E.G. Castillo Pérez,&nbsp;A. Nava-Castañeda","doi":"10.1016/j.oftal.2024.09.003","DOIUrl":"10.1016/j.oftal.2024.09.003","url":null,"abstract":"<div><h3>Background and objectives</h3><div>Endophthalmitis is a type of eye inflammation that affects all structures of the eye and is generally of infectious origin. In cases recalcitrant to intravitreal treatment or posterior vitrectomy, evisceration or enucleation are the preferable options. Polymethylmethacrylate (PMMA) bone cement stands out as an implant in other areas of medicine due to its great stability and healing. In this study, we will evaluate the safety profile and extrusion rate of the antibiotic-reinforced bone cement implantation when it is decided to place it at the same surgical act as an evisceration indicated for infective endophthalmitis.</div></div><div><h3>Materials and methods</h3><div>Subjects of any age and gender from the Oculoplastic outpatient clinic of Instituto de Oftalmología Fundación Conde de Valenciana, with a diagnosis of infectious endophthalmitis who required evisceration from May throught October 2012 were included.</div></div><div><h3>Results</h3><div>A total of 20 subjects were included, 55% of whom were men (11) 45% women (9), with mean age of 51 up to 80<!--> <!-->years. No complications were evidenced in the immediate postoperative period or at 1, 3 and 6<!--> <!-->months follow up, and in all cases, the correct position of the implant was confirmed via computed tomography.</div></div><div><h3>Conclusions</h3><div>In patients diagnosed with infectious endophthalmitis of any cause, evisceration and bone cement implatation in a single surgical act is a safe and effective option.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 87-90"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manejo exitoso de una hemorragia subretiniana en un paciente con DMAE
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.07.008
A. Miranda Sánchez, R. Fernández Narros, J. Donate López
{"title":"Manejo exitoso de una hemorragia subretiniana en un paciente con DMAE","authors":"A. Miranda Sánchez,&nbsp;R. Fernández Narros,&nbsp;J. Donate López","doi":"10.1016/j.oftal.2024.07.008","DOIUrl":"10.1016/j.oftal.2024.07.008","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Page 115"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementación de SICS (cirugía de catarata de pequeña incisión) en campañas humanitarias: descripción de la técnica quirúrgica y revisión de la literatura
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.10.004
D. Berrones , C. Rocha-de-Lossada , E. Barraquer-Compte , G. Valvecchia , Joaquín Fernández
The aim of this article has been, on the one hand, to describe the use of manual small incision cataract surgery (MSICS) for the management of cataracts, especially mature ones, in relation to its particular utility in the field of humanitarian campaigns, for which a description of the MSICS technique has been made, subsequently a review of the available scientific literature has been carried out to verify the results of this technique in comparison with phacoemulsification and extracapsular surgery and to describe the importance of teaching this technique to all cataract surgeons, especially the ones participating in humanitarian campaigns. According to what has been found, MSICS is an excellent surgical technique and according to current evidence it seems to be the choice over phacoemulsification and/or the classic extracapsular technique in hyper mature cataracts, especially in the field of humanitarian campaigns, due to its lower rate of complications and the improvement in visual acuity obtained. According to the studies found, it would be possible for the experienced ophthalmologic surgeon to implement this technique since the learning curve is short. In addition, in the scenario of humanitarian campaigns, the cost per surgery and the surgical time are reduced. It can be concluded that MSICS should be part of the surgical repertoire of every cataract surgeon, especially in those who perform surgeries in humanitarian campaigns, since it provides shorter surgical time, lower cost and better results in complex cases.
{"title":"Implementación de SICS (cirugía de catarata de pequeña incisión) en campañas humanitarias: descripción de la técnica quirúrgica y revisión de la literatura","authors":"D. Berrones ,&nbsp;C. Rocha-de-Lossada ,&nbsp;E. Barraquer-Compte ,&nbsp;G. Valvecchia ,&nbsp;Joaquín Fernández","doi":"10.1016/j.oftal.2024.10.004","DOIUrl":"10.1016/j.oftal.2024.10.004","url":null,"abstract":"<div><div>The aim of this article has been, on the one hand, to describe the use of manual small incision cataract surgery (MSICS) for the management of cataracts, especially mature ones, in relation to its particular utility in the field of humanitarian campaigns, for which a description of the MSICS technique has been made, subsequently a review of the available scientific literature has been carried out to verify the results of this technique in comparison with phacoemulsification and extracapsular surgery and to describe the importance of teaching this technique to all cataract surgeons, especially the ones participating in humanitarian campaigns. According to what has been found, MSICS is an excellent surgical technique and according to current evidence it seems to be the choice over phacoemulsification and/or the classic extracapsular technique in hyper mature cataracts, especially in the field of humanitarian campaigns, due to its lower rate of complications and the improvement in visual acuity obtained. According to the studies found, it would be possible for the experienced ophthalmologic surgeon to implement this technique since the learning curve is short. In addition, in the scenario of humanitarian campaigns, the cost per surgery and the surgical time are reduced. It can be concluded that MSICS should be part of the surgical repertoire of every cataract surgeon, especially in those who perform surgeries in humanitarian campaigns, since it provides shorter surgical time, lower cost and better results in complex cases.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 91-97"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rituximab intraorbitario para tratar inflamación orbitaria en paciente con neoplasia activa
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.09.002
P. Rivera Pérez de Rada, M. Cobas Belso, S. Vallinas Hidalgo, A. Ruibal Escribano, E. Barastay Alberdi, M. Benedí Alcibar
A 66-year-old woman presents with unilateral orbital inflammation of several years of evolution, initially classified as idiopathic orbital inflammatory disease (IOID) subtype myositis. She presented with pain, eyelid inflammation and significant elevation of intraocular pressure, as well as radiological signs of exophthalmos and superior rectus myositis. She was treated with corticosteroids, with partial response. She was diagnosed with colon adenocarcinoma, complicated with febrile neutropenia, and therefore immunosuppressive treatment was contraindicated. Treatment with intraorbital rituximab was decided, achieving resolution of symptoms and reduction of IOP. The diagnosis of neoplasia raises the possibility of paraneoplastic orbital inflammation.
{"title":"Rituximab intraorbitario para tratar inflamación orbitaria en paciente con neoplasia activa","authors":"P. Rivera Pérez de Rada,&nbsp;M. Cobas Belso,&nbsp;S. Vallinas Hidalgo,&nbsp;A. Ruibal Escribano,&nbsp;E. Barastay Alberdi,&nbsp;M. Benedí Alcibar","doi":"10.1016/j.oftal.2024.09.002","DOIUrl":"10.1016/j.oftal.2024.09.002","url":null,"abstract":"<div><div>A 66-year-old woman presents with unilateral orbital inflammation of several years of evolution, initially classified as idiopathic orbital inflammatory disease (IOID) subtype myositis. She presented with pain, eyelid inflammation and significant elevation of intraocular pressure, as well as radiological signs of exophthalmos and superior rectus myositis. She was treated with corticosteroids, with partial response. She was diagnosed with colon adenocarcinoma, complicated with febrile neutropenia, and therefore immunosuppressive treatment was contraindicated. Treatment with intraorbital rituximab was decided, achieving resolution of symptoms and reduction of IOP. The diagnosis of neoplasia raises the possibility of paraneoplastic orbital inflammation.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 103-106"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importancia del tratamiento individualizado: dispositivo subconjuntival en el glaucoma inducido por aceite de silicona
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.11.004
J. Avilés-Prieto , M. Parrila-Vallejo , C. Cortes-Laborda , P. Molina-Solana , S. Dominguez-Llamas , E. Rodríguez-de-la-Rúa-Franch
Although silicone oil is used as an intraocular buffer in vitreoretinal surgical procedures, its use can cause complications, including glaucoma. This study highlights the importance of individualized approaches for the management of silicone oil-induced glaucoma.
A 62-year-old man with a past medical history of retinal detachment and multiple ocular surgical procedures presented with uncontrolled ocular pressure peaks after retinal detachment surgery using silicone oil as a buffer, which did not resolve after removal of the buffer. We decided to perform anterior chamber lavage followed by the implantation of a subconjunctival drainage device in the lower nasal location to minimize complications and maintain good visual acuity. Silicone oil extraction is usually the treatment of choice, although it can cause fluctuations in intraocular pressure. In this case, a more physiological and less invasive approach was chosen with the implantation of a Preserflo® device in the lower nasal region, avoiding complications and achieving the preoperative goals without uneventfully.
{"title":"Importancia del tratamiento individualizado: dispositivo subconjuntival en el glaucoma inducido por aceite de silicona","authors":"J. Avilés-Prieto ,&nbsp;M. Parrila-Vallejo ,&nbsp;C. Cortes-Laborda ,&nbsp;P. Molina-Solana ,&nbsp;S. Dominguez-Llamas ,&nbsp;E. Rodríguez-de-la-Rúa-Franch","doi":"10.1016/j.oftal.2024.11.004","DOIUrl":"10.1016/j.oftal.2024.11.004","url":null,"abstract":"<div><div>Although silicone oil is used as an intraocular buffer in vitreoretinal surgical procedures, its use can cause complications, including glaucoma. This study highlights the importance of individualized approaches for the management of silicone oil-induced glaucoma.</div><div>A 62-year-old man with a past medical history of retinal detachment and multiple ocular surgical procedures presented with uncontrolled ocular pressure peaks after retinal detachment surgery using silicone oil as a buffer, which did not resolve after removal of the buffer. We decided to perform anterior chamber lavage followed by the implantation of a subconjunctival drainage device in the lower nasal location to minimize complications and maintain good visual acuity. Silicone oil extraction is usually the treatment of choice, although it can cause fluctuations in intraocular pressure. In this case, a more physiological and less invasive approach was chosen with the implantation of a Preserflo® device in the lower nasal region, avoiding complications and achieving the preoperative goals without uneventfully.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 111-114"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalencia de manifestaciones oculares por deficiencia de vitamina A en niños: revisión sistemática
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.08.014
S. Castro-Pachón, S. Perilla-Soto, K. Ruiz-Sarmiento, J.A. Niño-García, M.J. Sánchez-Rosso, M.C. Ordóñez-Caro, D.S. Camacho-Páez, D. García-Lozada

Objective

Identify the prevalence of ocular signs due to vitamin A in children.

Methods

We conducted a systematic search in September 2022. Observational studies with populations between 0-18 years old, who had ocular signs due to vitamin A deficiency, were included. Studies with selected subjects with underlying diseases were excluded. The results were exported to the Rayyan tool for duplicate removal and paired reading. The methodological quality assessment of the included articles was carried out with the Agency for Healthcare Research and Quality Institute instrument.

Results

79 studies published from 1972 through 2020 were included, conducted mainly in Asia 42 (53%) and Africa 28 (35.4%). In America, 4 studies were from Brazil; no research was found in Europe. The most reported ocular manifestations due to vitamin A were: xerophthalmia in 38.0% of the articles and night blindness in 69.6%, being more common in the general population (76.3%) and less in aborigines (1.9%). The diagnostic methods used were: surveys (82.3%), laboratory tests (32%), ocular evaluation by optometry or ophthalmologist (25.3%) and ocular examination by trained personnel (8.9%). The studies were conducted among the general population (79.7%), hospitals (15.2%), schools for the blind (2.5%), migrants in transit (1.3%) and aborigines (1.3%).

Conclusion

Ocular signs continue to represent a public health problem that affects children from 0 to 18 years of age on 4 continents, with greater emphasis on Asia and Africa. Additional studies are required to understand the impact of vitamin A deficiency in Latin America.
{"title":"Prevalencia de manifestaciones oculares por deficiencia de vitamina A en niños: revisión sistemática","authors":"S. Castro-Pachón,&nbsp;S. Perilla-Soto,&nbsp;K. Ruiz-Sarmiento,&nbsp;J.A. Niño-García,&nbsp;M.J. Sánchez-Rosso,&nbsp;M.C. Ordóñez-Caro,&nbsp;D.S. Camacho-Páez,&nbsp;D. García-Lozada","doi":"10.1016/j.oftal.2024.08.014","DOIUrl":"10.1016/j.oftal.2024.08.014","url":null,"abstract":"<div><h3>Objective</h3><div>Identify the prevalence of ocular signs due to vitamin<!--> <!-->A in children.</div></div><div><h3>Methods</h3><div>We conducted a systematic search in September 2022. Observational studies with populations between 0-18 years old, who had ocular signs due to vitamin<!--> <!-->A deficiency, were included. Studies with selected subjects with underlying diseases were excluded. The results were exported to the Rayyan tool for duplicate removal and paired reading. The methodological quality assessment of the included articles was carried out with the Agency for Healthcare Research and Quality Institute instrument.</div></div><div><h3>Results</h3><div>79 studies published from 1972 through 2020 were included, conducted mainly in Asia 42 (53%) and Africa 28 (35.4%). In America, 4 studies were from Brazil; no research was found in Europe. The most reported ocular manifestations due to vitamin<!--> <!-->A were: xerophthalmia in 38.0% of the articles and night blindness in 69.6%, being more common in the general population (76.3%) and less in aborigines (1.9%). The diagnostic methods used were: surveys (82.3%), laboratory tests (32%), ocular evaluation by optometry or ophthalmologist (25.3%) and ocular examination by trained personnel (8.9%). The studies were conducted among the general population (79.7%), hospitals (15.2%), schools for the blind (2.5%), migrants in transit (1.3%) and aborigines (1.3%).</div></div><div><h3>Conclusion</h3><div>Ocular signs continue to represent a public health problem that affects children from 0 to 18<!--> <!-->years of age on 4 continents, with greater emphasis on Asia and Africa. Additional studies are required to understand the impact of vitamin<!--> <!-->A deficiency in Latin America.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 69-86"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Escleritis secundaria a infección por Pseudomonas aeruginosa imitando escleritis necrosante autoinmune. Un caso clínico
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.08.016
M.L. Quezada-Osoria , G.R. Vera-Duarte , M. Pedroza-Seres
To report a case of spontaneous-onset unilateral scleritis and keratitis due to Pseudomonas aeruginosa in a patient with systemic lupus erythematosus who partially responded to antibiotic therapy and achieved complete resolution after IV immunotherapy. A 30-year-old woman with a past medical history of hypothyroidism and systemic lupus erythematosus and on irregular therapy presented with a long-history of thinning of the sclera and cornea refractory to antibiotic therapy despite a positive culture for P. aeruginosa, which eventually resolved with the implementation of immunotherapy. Infectious scleritis is an uncommon and diagnostically challenging scleral inflammation. However; we must rule it out in patients with autoimmune diseases due to the inherent risk of these patients as their immune system has been impaired.
{"title":"Escleritis secundaria a infección por Pseudomonas aeruginosa imitando escleritis necrosante autoinmune. Un caso clínico","authors":"M.L. Quezada-Osoria ,&nbsp;G.R. Vera-Duarte ,&nbsp;M. Pedroza-Seres","doi":"10.1016/j.oftal.2024.08.016","DOIUrl":"10.1016/j.oftal.2024.08.016","url":null,"abstract":"<div><div>To report a case of spontaneous-onset unilateral scleritis and keratitis due to <em>Pseudomonas aeruginosa</em> in a patient with systemic lupus erythematosus who partially responded to antibiotic therapy and achieved complete resolution after IV immunotherapy. A 30-year-old woman with a past medical history of hypothyroidism and systemic lupus erythematosus and on irregular therapy presented with a long-history of thinning of the sclera and cornea refractory to antibiotic therapy despite a positive culture for <em>P. aeruginosa</em>, which eventually resolved with the implementation of immunotherapy. Infectious scleritis is an uncommon and diagnostically challenging scleral inflammation. However; we must rule it out in patients with autoimmune diseases due to the inherent risk of these patients as their immune system has been impaired.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 107-110"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
¿Es la investigación una obligación ética para los oftalmólogos hospitalarios y académicos?
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.10.009
J.C. Pastor , J.A. Fernández-Vigo
{"title":"¿Es la investigación una obligación ética para los oftalmólogos hospitalarios y académicos?","authors":"J.C. Pastor ,&nbsp;J.A. Fernández-Vigo","doi":"10.1016/j.oftal.2024.10.009","DOIUrl":"10.1016/j.oftal.2024.10.009","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 59-60"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oclusión combinada de vena central de la retina y arteria ciliorretiniana en dos pacientes jóvenes
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.08.006
M. Comes-Carsí, E. Gracia-Rovira, L. Manfreda-Domínguez, V.T. Pérez-Torregrosa, J.P. Liscombe-Sepúlveda, A.M. Duch-Samper
We present 2 cases reports of central retinal vein occlusion (CRVO) along with cilioretinal artery occlusion (CRAO) in young patients with no cardiovascular risk factors (CVRF) or past medical history of interest. We conducted an extensive etiological study with analytical and imaging tests without finding relevant changes. Finally, in case report 1, the intake of 1 postcoital contraceptive pill was considered the triggering cause while, in case report 2, the etiology was attributed to a previous infection by the SARS-Cov-2 virus. On both cases, antiplatelet therapy was initiated. In both patients disease progression was favorable, with good visual recovery.
{"title":"Oclusión combinada de vena central de la retina y arteria ciliorretiniana en dos pacientes jóvenes","authors":"M. Comes-Carsí,&nbsp;E. Gracia-Rovira,&nbsp;L. Manfreda-Domínguez,&nbsp;V.T. Pérez-Torregrosa,&nbsp;J.P. Liscombe-Sepúlveda,&nbsp;A.M. Duch-Samper","doi":"10.1016/j.oftal.2024.08.006","DOIUrl":"10.1016/j.oftal.2024.08.006","url":null,"abstract":"<div><div>We present 2 cases reports of central retinal vein occlusion (CRVO) along with cilioretinal artery occlusion (CRAO) in young patients with no cardiovascular risk factors (CVRF) or past medical history of interest. We conducted an extensive etiological study with analytical and imaging tests without finding relevant changes. Finally, in case report 1, the intake of 1 postcoital contraceptive pill was considered the triggering cause while, in case report 2, the etiology was attributed to a previous infection by the SARS-Cov-2 virus. On both cases, antiplatelet therapy was initiated. In both patients disease progression was favorable, with good visual recovery.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 98-102"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidencia y causas de los retratamientos en pacientes miopes intervenidos de LASIK con monovisión inducida, sin prueba preoperatoria de tolerancia de la misma con lentes de contacto
Q3 Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.oftal.2024.08.011
M. García González , M.A. Teus Guezala

Purpose

To evaluate the incidence and causes of the need for retreatment after LASIK-induced monovision in patients with myopia and presbyopia without a previous trial of contact lens induced monovision.

Design

Retrospective, observational study.

Methods

We retrospectively studied 914 eyes of 457 consecutive myopic patients with presbyopia scheduled for LASIK-induced monovision (nondominant eye corrected for near). The dominant eye was identified by the finger pointing test and the treatment plan for the nondominant eye ranged from -0.50 to -1.50 diopters based on an age-related nomogram. We evaluated the incidence of enhancements and the causes at 6 months postoperatively. Patients were divided into three groups based on age to evaluate possible differences in the reasons for retreatment among the age groups.

Results

The global enhancement rate was 15,8% (144/914 eyes). The incidence of retreatment was significantly higher in the dominant eye (8,6%) than in the nondominant eye (7,1%) (P = 0.01). The enhancement rate in the nondominant eye were conversion to full distance (8,8% of patients), induction of more monovision (3,2% of patients) and reduction of anisometropia (1,1% of patients). More young patients (aged 40 to 45 years) wanted to reverse the procedure.

Conclusions

LASIK-induced monovision is a valid option for myopic patients with presbyopia, with a relatively low incidence of enhancements. The low retreatment rate to reverse monovision is a good index of patient tolerance and satisfaction with the results of the procedure. For this reason, a preoperative trial of monovision with contact lenses should not be mandatory before LASIK.
{"title":"Incidencia y causas de los retratamientos en pacientes miopes intervenidos de LASIK con monovisión inducida, sin prueba preoperatoria de tolerancia de la misma con lentes de contacto","authors":"M. García González ,&nbsp;M.A. Teus Guezala","doi":"10.1016/j.oftal.2024.08.011","DOIUrl":"10.1016/j.oftal.2024.08.011","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the incidence and causes of the need for retreatment after LASIK-induced monovision in patients with myopia and presbyopia without a previous trial of contact lens induced monovision.</div></div><div><h3>Design</h3><div>Retrospective, observational study.</div></div><div><h3>Methods</h3><div>We retrospectively studied 914 eyes of 457 consecutive myopic patients with presbyopia scheduled for LASIK-induced monovision (nondominant eye corrected for near). The dominant eye was identified by the finger pointing test and the treatment plan for the nondominant eye ranged from -0.50 to -1.50 diopters based on an age-related nomogram. We evaluated the incidence of enhancements and the causes at 6 months postoperatively. Patients were divided into three groups based on age to evaluate possible differences in the reasons for retreatment among the age groups.</div></div><div><h3>Results</h3><div>The global enhancement rate was 15,8% (144/914 eyes). The incidence of retreatment was significantly higher in the dominant eye (8,6%) than in the nondominant eye (7,1%) (<em>P</em> <!-->=<!--> <!-->0.01). The enhancement rate in the nondominant eye were conversion to full distance (8,8% of patients), induction of more monovision (3,2% of patients) and reduction of anisometropia (1,1% of patients). More young patients (aged 40 to 45 years) wanted to reverse the procedure.</div></div><div><h3>Conclusions</h3><div>LASIK-induced monovision is a valid option for myopic patients with presbyopia, with a relatively low incidence of enhancements. The low retreatment rate to reverse monovision is a good index of patient tolerance and satisfaction with the results of the procedure. For this reason, a preoperative trial of monovision with contact lenses should not be mandatory before LASIK.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 2","pages":"Pages 61-68"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archivos De La Sociedad Espanola De Oftalmologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1